Stock Events

Stock Events

Spyre Therapeutics (3920.STU) Q2 2026 Earnings

5MayConfirmed

Q1 2026

Q2 2026

-0.63

-0.61

-0.59

-0.57

Details

Expected EPS

-0.56804283909

Actual EPS

-0.6315086

Surprise EPS

-0.06

Surprise Percent

+11.17%

Description

Spyre Therapeutics (3920.STU) has reported earnings of -0.6315086 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.